Case report: Circulating tumor DNA technology displays temporal and spatial heterogeneity in Waldenström macroglobulinemia during treatment with BTK inhibitors

• 主要な著者: Jingjing Zhu (著者), Xinyu Zhu (著者), Fengyang Xie (著者), Yi Ding (著者), Huina Lu (著者), Yan Dong (著者), Ping Li (著者), Jianfei Fu (著者), Aibin Liang (著者), Yu Zeng (著者), Bing Xiu (著者)
• フォーマット: 図書
• 出版事項: Frontiers Media S.A., 2023-04-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Waldenström macroglobulinemia (WM) is a rare subtype of B-cell lymphoma. Rituximab-based combination therapy and Bruton's tyrosine kinase (BTK) inhibitors have greatly improved the prognosis of WM. Despite the high response rate and good tolerance of BTK inhibitors in treatment of...